Skip to main content

Table 1 Baseline characteristics of subjects

From: Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease

Age (years)

67 ± 10

Male (%)

84 (83 %)

Body mass index (kg/m2)

24.3 ± 3.4

Hypertension (%)

66 (65 %)

Diabetes (%)

45 (45 %)

Family history of CAD (%)

10 (10 %)

Smoking (%)

23 (23 %)

Treated with ACE inhibitors or ARBs (%)

55 (54 %)

Treated with CCBs (%)

54 (53 %)

Treated with beta-blockers (%)

10 (10 %)

  1. Data are expressed as the means ± SD or number (%)
  2. ACE angiotensin-converting enzyme, ARBs angiotensin-receptor blockers, CCBs calcium channel blockers